ChromaTide™ Alexa Fluor™ 488-5-dUTP
ChromaTide™ Alexa Fluor™ 488-5-dUTP
Invitrogen™

ChromaTide™ Alexa Fluor™ 488-5-dUTP

Molecular Probes™ ChromaTide™色素標識dUTP、OBEA-dCTP、およびUTPヌクレオチドは、有害で高価な放射性同位体標識ヌクレオチドを必要とせずに、標識DNAプローブを合成するために使用できます。これらのヌクレオチドは、標準的な分子生物学テクノロジーを使用して組み込むことができます。標識プローブはその後詳細を見る
製品番号(カタログ番号)数量
C1139725 μL
製品番号(カタログ番号) C11397
価格(JPY)
78,600
온라인 행사
Ends: 27-Mar-2026
131,000
割引額 52,400 (40%)
Each
お問い合わせください ›
数量:
25 μL
Molecular Probes™ ChromaTide™色素標識dUTP、OBEA-dCTP、およびUTPヌクレオチドは、有害で高価な放射性同位体標識ヌクレオチドを必要とせずに、標識DNAプローブを合成するために使用できます。これらのヌクレオチドは、標準的な分子生物学テクノロジーを使用して組み込むことができます。標識プローブはその後、in situハイブリダイゼーション、マイクロアレイ、またはブロッティングプロトコルに使用できます。ChromaTide™色素標識ヌクレオチドは、さまざまな蛍光色で提供されており、マルチカラー分析を容易にします。

ChromaTide™標識ヌクレオチドの仕様:
•色素の励起/発光:Alexa Fluor™ 488-5-dUTP(490/520 nm)
•アルキニルアミノリンカーの長さ:5つの原子


ChromaTideヌクレオチドをプローブに組み込む方法
• ニックトランスレーション
• ランダムプライマー標識化
• 末端デオキシヌクレオチド転移酵素による末端の標識化
• 逆転写酵素
• PCR増幅


これらの各方法に固有のガイドラインについては、ChromaTide™ dUTPの酵素的組み込み法を参照してください。

Alexa Fluor™およびBODIPY™蛍光色素が高度なプローブを実現
標識ヌクレオチドで作成されたプローブは、in situハイブリダイゼーションやアレイへのハイブリダイゼーションなどのマルチカラーテクノロジーに使用できます。当社独自のBODIPY™およびAlexa Fluor™色素コンジュゲートは、非常に明るく、光安定性が高く、本質的にpHに影響しません。BODIPY™色素の狭い発光プロファイルは、スペクトルのオーバーラップを最小限に抑えます。Alexa Fluor™色素は、これらから作成されるDNAプローブと同様に水溶性が高く、蛍光in situハイブリダイゼーションに最適な標識です。

長いリンカーにより性能が向上
ChromaTide™ dUTPおよびUTPヌクレオチドは、独自のアルキルアミノリンカーを介して、ウリジンのC-5位置で修飾されます。これによって、ヌクレオチドと色素の間にスペーサーが提供され、それらの相互作用が低減します。製品名の数字(例えば、fluorescein-12-dUTPの“12”)は、原子におけるスペーサーの正味長を示します。これらのスペーサーにより、二次検出試薬のコンジュゲートが明るくなり、ハプテンへのアクセス性が向上します。

当社のChromaTide™試薬の完全なリストについては、以下をご覧ください。Molecular Probes ChromaTide™およびAHA標識ヌクレオチド—表8.5
これらの標識試薬の詳細については、Molecular Probes™ハンドブックのオリゴヌクレオチドと核酸の標識化—セクション 8.2を参照してください。

研究用途にのみご使用ください。ヒトまたは動物の治療もしくは診断用には使用できません。
研究用にのみ使用できます。診断用には使用いただけません。
仕様
標識法直接標識
標識または色素Alexa Fluor™ 488
数量25 μL
出荷条件ドライアイス
濃度1 mM
製品ラインAlexa Fluor、ChromaTide, ChromaTide
Unit SizeEach
組成および保存条件
フリーザー(-5∼-30度)に保存し、遮光してください。

よくあるご質問(FAQ)

I'm getting high background after labeling with ChromaTide nucleotides. What do you recommend I do?

You can try to purify the ChromaTide labeled probe with an appropriate spin column-based method to remove unincorporated ChromaTide nucleotides. Ethanol precipitation may not efficiently remove the unincorporated ChromaTide nucleotides, so a spin column will need to be used.

The nucleic acid probe is not fluorescent after labeling with ChromaTide nucleotides. What do you recommend I try?

- Check the base-to-dye ratio to determine the level of incorporation of the ChromaTide nucleotides. Since fluorescent detection may be affected by underlabeling, overlabeling, instrument sensitivity, or other factors, the base-to-dye ratio is a better indicator of incorporation efficiency.
- ChromaTide nucleotides may not have been incorporated well in the enzymatic labeling reaction. Make sure that the enzymatic method used is compatible with the particular fluorescent ChromaTide nucleotide, since some methods may not be appropriate for all applications. You may also need to further optimize the enzymatic incorporation method, for example by optimizing enzyme concentration, incubation time, concentration, and ratio of labeled and unlabeled nucleotides. For PCR, a lower fidelity polymerase may give higher incorporation rates; however, incorporation rates will be generally low using PCR.
- Check the fluorescent filter used for detection to make sure it is compatible with the dye. You can also test a small drop of the undiluted fluorescent ChromaTide nucleotide in your filter to make sure you can image the dye alone before it is conjugated to the oligonucleotide. The fluorescence emission of Alexa Fluor 647 is not visible by eye and will require a far-red imaging system for detection.

Can ChromaTide nucleotides be used for labeling nucleic acids in live cells?

No, they are not cell permeant so they are only suitable for in vitro incorporation methods. The fluorescent dyes and phosphate groups are too highly charged to allow the nucleotides to penetrate the membrane of an intact cell. Nonfluorescent nucleosides without phosphates such as EdU, EU, or BrdU can be used for live cell nucleic acid incorporation studies.

How do I determine the incorporation efficiency of the ChromaTide Labeling Nucleotides after enzymatic incorporation?

The base-to-dye ratio is determined by measuring the absorbance of the nucleic acid at 260 nm and the absorbance of the dye at its absorbance maximum. Using the extinction coefficients for the appropriate dye and nucleic acid, you can then calculate the base-to-dye ratio for the labeled nucleic acid using the Beer-Lambert law. Detailed instructions can be found in these product manuals: (http://tools.thermofisher.com/content/sfs/manuals/td07604.pdf, http://tools.thermofisher.com/content/sfs/manuals/td07605.pdf).

What is the average dye to base incorporation rate when enzymatically incorporating ChromaTide nucleotides?

The average incorporation is one dye for every 100-150 bases, so the ChromaTide fluorescently labeled nucleotides typically produce the lowest labeling rates of the nucleic acid labeling methods we offer.

引用および参考文献 (14)

引用および参考文献
Abstract
Super-resolution imaging reveals three-dimensional folding dynamics of the ß-globin locus upon gene activation.
Authors:van de Corput MP, de Boer E, Knoch TA, van Cappellen WA, Quintanilla A, Ferrand L, Grosveld FG,
Journal:J Cell Sci
PubMed ID:22767512
The chromatin architecture is constantly changing because of cellular processes such as proliferation, differentiation and changes in the expression profile during gene activation or silencing. Unravelling the changes that occur in the chromatin structure during these processes has been a topic of interest for many years. It is known that ... More
Heterogeneous nuclear ribonucleoprotein (hnRNP) E1 binds to hnRNP A2 and inhibits translation of A2 response element mRNAs.
Authors:Kosturko LD, Maggipinto MJ, Korza G, Lee JW, Carson JH, Barbarese E
Journal:Mol Biol Cell
PubMed ID:16775011
'Heterogeneous nuclear ribonucleoprotein (hnRNP) A2 is a trans-acting RNA-binding protein that mediates trafficking of RNAs containing the cis-acting A2 response element (A2RE). Previous work has shown that A2RE RNAs are transported to myelin in oligodendrocytes and to dendrites in neurons. hnRNP E1 is an RNA-binding protein that regulates translation of ... More
Effects of RNA interference of Trypanosoma brucei structure-specific endonuclease-I on kinetoplast DNA replication.
Authors:Liu Y, Motyka SA, Englund PT
Journal:J Biol Chem
PubMed ID:16096280
'Kinetoplast DNA, the mitochondrial DNA of trypanosomatid protozoa, is a network containing several thousand topologically interlocked DNA minicircles. Kinetoplast DNA synthesis involves release of minicircles from the network, replication of the free minicircles, and reattachment of the progeny back onto the network. One enzyme involved in this process is structure-specific ... More
A beta-catenin survival signal is required for normal lobular development in the mammary gland.
Authors:Tepera SB, McCrea PD, Rosen JM,
Journal:J Cell Sci
PubMed ID:12584256
'The Wnt (wingless) family of secreted glycoproteins initiates a signalling pathway implicated in the regulation of both normal mouse mammary gland development and tumorigenesis. Multiple Wnt signals ultimately converge on the multifunctional protein beta-catenin to activate the transcription of target genes. Although beta-catenin plays a crucial role in canonical Wnt ... More
The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies.
Authors:Korbel JO, Tirosh-Wagner T, Urban AE, Chen XN, Kasowski M, Dai L, Grubert F, Erdman C, Gao MC, Lange K, Sobel EM, Barlow GM, Aylsworth AS, Carpenter NJ, Clark RD, Cohen MY, Doran E, Falik-Zaccai T, Lewin SO, Lott IT, McGillivray BC, Moeschler JB, Pettenati MJ, Pueschel SM, Rao KW, Shaffer LG, Shohat M, Van Riper AJ, Warburton D, Weissman S, Gerstein MB, Snyder M, Korenberg JR,
Journal:Proc Natl Acad Sci U S A
PubMed ID:19597142
'Down syndrome (DS), or trisomy 21, is a common disorder associated with several complex clinical phenotypes. Although several hypotheses have been put forward, it is unclear as to whether particular gene loci on chromosome 21 (HSA21) are sufficient to cause DS and its associated features. Here we present a high-resolution ... More